p27/Kip1 mutation found in breast cancer

Cancer Research

Volumn 56, Issue 10, 1996, Pages 2400-2404

  Spirin, Konstantin S ^a   Simpson, Jean F ^b   Takeuchi, Seisho ^a   Kawamata, Norihiko ^a   Miller, Carl W ^a   Koeffler, H Phillip ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; DNA; ENZYME INHIBITOR; REGULATOR PROTEIN;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CHROMOSOMAL LOCALIZATION; CHROMOSOME 12P; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENE MUTATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; SOUTHERN BLOTTING; TUMOR SUPPRESSOR GENE;

BASE SEQUENCE; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL CYCLE PROTEINS; CHROMOSOMES, HUMAN, PAIR 12; CODON; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; MICROSATELLITE REPEATS; MICROTUBULE-ASSOCIATED PROTEINS; MOLECULAR SEQUENCE DATA; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; SEQUENCE DELETION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0030002553     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (73)

1. Kamb, A. Cell-cycle regulators and cancer. Trends Genet , 11, 136-140, 1995.
2. Cordon-Cardo, C. Mutations of cell cycle regulators. Biological and clinical implications for human neoplasia. Am J. Pathol., 147: 545-560, 1995.
3. Hunter, T , and Pines, J. Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age Cell, 79. 573-582, 1994.
4. Sherr, C. J. D-type cyclins. Trends Biochem. Sci , 20: 187-190, 1995.
5. Wang, J. Y. J., Knudsen, E. S , and Welch, P. J. The retinoblastoma tumor suppressor protein. Adv. Cancer Res., 64: 25-85, 1994.
6. Adams, P. D., and Kaelin, W G., Jr Transcriptional control by E2F. Semin. Cancer Biol., 6: 99-108, 1995.
7. Kranenburg, O , van der Eb, A. J , and Zantema, A. Cyclin-dependent kinases and pRb: regulators of the proliferation-differentiation switch FEBS Lett., 367: 103-106, 1995.
8. Harper, J W., Elledge, S. J., Keyomarsi, K., Dynlacht, B., Tsai, L. H., Zhang, P., Dobrowolski, S , Bai, C , Connell-Crowley, L , Swindell, E , Fox, M P., and Wei, N. Inhibition of cyclin-dependent kinases by p21. Mol. Biol. Cell, 6: 387-400, 1995.
9. Hatakeyama, M., Brill, J. A., Fink, G. R , and Weinberg, R. A Collaboration of cyclin genes in the functional inactivation of the retinoblastoma protein. Genes & Dev., 8: 1759-1771, 1994.
10. 1 phase progression: cyclin on cue. Cell, 79: 1059-1065, 1994.
11. 1 control in mammalian cells. J. Cell Sci., 18: 69-73, 1994.
12. Jackson, P. K., Chevalier, S., Philippe, M , and Kirschner, M. W. Early events in DNA replication require cyclin E and are blocked by p21/CIP1. J. Cell Biol., 130: 755-69, 1995.
13. Hirama, T., and Koeffler, H. P. Role of the cyclin-dependent kinase inhibitors in the development of cancer. Blood, 86: 841-54, 1995.
14. 1 cyclin-dependent kinases. Genes & Dev , 9: 1149-1163, 1995.
15. Peter, M , and Herskowitz, I Joining the complex: cyclin dependent kinase inhibitory proteins and the cell cycle. Cell, 79. 181-184, 1994.
16. Serrano, M., Hannon, G. J., and Beach, D. A new regulatory motif in cell cycle inhibition of cyclin D/cdk4. Nature (Lond), 366, 704-707, 1993.
17. Hannon, G. J , and Beach, D p15/INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature (Lond.), 371: 257-261, 1994.
18. Guan, K. L., Jenkins, C. W., Li, Y , Nichols, M. A., Wu, X., O'Keefe, C. L., Matera, A G , and Xiong, Y Growth suppression by p18, a p16INK4/MTSI- and p14INK4B/ MTS2-related CDK6 inhibitor, correlates with wild-type pRb function. Genes & Dev., 8: 2939-2952, 1994.
19. Hirai, H , Roussel, M. F , Kato, J Y., Ashmun, R. A., and Sherr, C. J. Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6. Mol. Cell. Biol., 15 2672-2681, 1995.
20. Chan F. K., Zhang, J., Cheng, L., Shapiro, D. N., and Winoto, A. Identification of human and mouse p19, a novel CDK4and CDK6 inhibitor with homology to p16ink4. Mol. Cell Biol., 15: 2682-2688, 1995.
21. Tam, S. W., Shay, J. W., and Pagano, M. Differential expression and cell cycle regulation of the cyclin-dependent kinase 4 inhibitor p16/INK4. Cancer Res., 54: 5816-5820, 1994
22. Jin, X., Nguyen, D Zhang, W. W , Kyntsis, A. P., and Roth, J A. Cell cycle arrest and inhibition of tumor cell proliferation by the p16/INK4 gene mediated by an adenovirus vector. Cancer Res., 55: 3250-3253, 1995.
23. Reed, J. A., Loganzo, F., Jr , Shea, C R., Walker, G. J., Flores, J. F., Glendening, J. M. Bogdany, J K., Shiel, M J., Haluska, F. G., and Fountain, J W. Loss of expression of the p16/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression. Cancer Res., 55: 2713-2718, 1995.
24. Sill, H., Goldman, J. M., and Cross, N. Homozygous deletions of the p16 tumor-suppressor gene are associated with lymphoid transformation of chronic myeloid leukemia. Blood, 85: 2013-2016, 1995.
25. Xiong, Y., Hannon, G. J , Zhang, H , Casso, D., Kobayashi, R., and Beach, D. p21 is a universal inhibitor of cyclin kinases. Nature (Lond), 366: 701-704, 1993
26. 1 cyclin-dependent kinases. Cell, 75: 805-816, 1993.
27. El-Deiry, W. S , Tokino, T., Velculescu, V. E., Levy, D. B , Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W , and Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell, 75: 817-825, 1993
28. Jiang, H , and Fisher, P. B. Use of a sensitive and efficient substraction hybridisation protocol for identification of genes differentially regulated during the induction of differentiation in human melanoma cells. Mol. Cell Differ., 1 285-299, 1993.
29. Noda, A., Ning, Y , Venable, S. F , Pereira-Smith, O. M , and Smith, J. R. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen Exp. Cell Res , 211. 90-98, 1994
30. Gu, Y., Turck, C. W., and Morgan, D O Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature (Lond.), 366: 707-710, 1993
31. Polyak, K., Kato, J Y., Solomon, M. J., Sherr, C J., Massague, J., Roberts, J M , and Koff, A. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest Genes & Dev., 8: 9-22, 1994.
32. Polyak, K , Lee, M. H., Erdjument-Bromage, H., Koff, A., Roberts, J M., Tempst, P., and Massague, J. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell, 78: 59-66, 1994.
33. 1 cyclin-Cdk protein kinase activity, is related to p21. Cell, 78: 67-74, 1994
34. Hengst, L , Dulic, V , Slingerland, J. M., Lees, E , and Reed, S. I. A cell cycle-regulated inhibitor of cyclin-dependent kinases. Proc Natl. Acad Sci. USA, 91: 5291-5295, 1994.
35. Matsuoka, S., Edwards, M C., Bai, C., Parker, S., Zhang, P , Baldini, A., Harper, J W , and Elledge, S J. p57/Kip2, a structurally distinct member of the p2/CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes & Dev., 15: 650-662, 1995
36. Lee, M. H , Reynisdottir, I., and Massague, J. Cloning of p57/Kip2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes & Dev., 9: 639-649, 1995
37. Chen, J., Jackson, P. K., Kirshner, M. W , and Dutta, A. Separate domains of p21 involved in the inhibition of cdk kinase and PCNA. Nature (Lond.), 374. 386-388, 1995
38. Luo, Y., Hurwitz, J., and Massague, J Cell-cycle inhibition by independent CDK and PCNA-binding domains in p21/Cip1. Nature (Lond.), 375: 159-161, 1995.
39. Elledge, S J., and Harper J. W. Cdk inhibitors: on the threshold of checkpoints and development. Curr Opin. Cell. Biol , 6: 847-852, 1994.
40. Nourse, J., Firpo, E , Flanagan, W. M., Coats, S., Polvak, K., Lee, M H., Massague, J , Crabtree, G R., and Roberts, J. M. Interleukin-2- mediated elimination of the p27/Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature (Lond.), 372: 570-573, 1994.
41. Ravitz, M. Yan, S., Herr, K. D., and Wenner, C. E Transforming growth factor beta-induced activation of cyclin E-cdk2 kinase and down-regulation of p27/Kip1 in C3H 10T1/2 mouse fibroblasts. Cancer Res., 55: 1413-1416, 1995
42. Kato, J. Y., Matsuoka, M., Polyak, K., Massague, J , and Sherr, C. J. Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27/Kip1) of cyclin-dependent kinase 4 activation. Cell, 79: 487-496, 1994.
43. Bartkova, J., Lukas, J., Strauss, M., and Bartek, J. Cyclin D1 oncoprotein aberrantly accumulates in malignancies of diverse histogenesis Oncogene, 10: 775-778, 1995
44. Zhang, S. Y., Caamano, J., Cooper, F., Guo, X , and Klein-Szanto, A. J. Immunohistochemistry of cyclin D1 in human breast cancer Am J Clin. Pathol., 102: 695-698, 1994.
45. Devilee, P., Schuuring, E. van de Vijver, M. J., and Cornelisse, C. J. Recent developments in the molecular genetic understanding of breast cancer Crit Rev. Oncol , 5: 247-270, 1994.
46. Cox, L. A , Chen, G , and Lee, E Y. Tumor suppressor genes and their roles in breast cancer. Breast Cancer Res. Treat., 32: 19-38, 1994.
47. Porter-Jordan, K. and Lippman, M. E. Overview of the biologic markers of breast cancer. Hematol Oncol. Clin. North Am., 8: 73-100, 1994.
48. Sawan, A., Randall, B., Angus, B., Wright, C., Henry, J. A., Ostrowski, J., Hennessy, C. Lennard, T. W , Corbett, I., and Horne, C. H. Retinoblastoma and p53 gene expression related to relapse and survival in human breast cancer an immunohistochemical study. J. Pathol , 168: 23-28, 1992
49. Callahan, R., Cropp, C. S., Merlo, G. R., Liscia, D. S., Cappa, A. P., and Lidereau, R Somatic mutations and human breast cancer. A status report. Cancer (Phila.). 69: 1582-1588, 1992.
50. 3 analogues: a novel class of potent inhibitors of proliferation and inducers of differentiation of human breast cancer cell lines. Cancer Res., 55: 2822-2830, 1995.
51. Xu, L., Sgroi, D., Sterner, C. J , Beauchamp, R. L., Pinney, D. M., Keel, S., Ueki, K., Rutter, J. L , Buckler, A. J., Louis, D. N., Gusella, J. F., and Ramesh, V. Mutational analysis of CDKN2 (MTS1/p16ink4) in human breast carcinomas. Cancer Res., 54: 5262-5264, 1994.
52. Rush, E. B , Abouezzi, Z , Borgen, P. I., and Anelli, A Analysis of MTS1/INK4 in female breast carcinomas Cancer Lett., 89: 223-226, 1995.
53. Kip1, chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors. Cancer Res , 55: 1211-1214, 1995
54. Pietenpol, J. A , Bohlander, S. K., Sato, Y., Papadopoulos, N , Liu, B , Friedman, C , Trask, B J., Roberts, J. M., Kinzler, K. W., Rowley, J. D., and Vogelstein, B. Assignment of the human p27/Kip1 gene to 12p13 and its analysis in leukemias. Cancer Res., 55: 1206-1210, 1995.
55. Kip1, to regions involved in human cancer. Cancer Res., 55: 1199-1205, 1995.
56. Takeuchi, S., Bartram, C. R., Seriu, T , Wada, M., Lee, E , and Koeffler, H P Allelotype of acute lymphoblastic leukemia (ALL) identifies sites of tumor suppressor genes Blood, 84 (Suppl. 1): 149a, 1994.
57. Sato, Y., Suto, Y., Pietenpol, J., Golub, T. R , Gilliland, D. G., Davis, E. M., Le Beau, M. M., Roberts, J. M., Vogelstein, B., Rowley, J. D., and Bohlander, S. K. TEL and Kip1 define the smallest region of deletions on 12p13 in hematopoietic malignancies. Blood, 86 1525-1533, 1995
58. Stegmaier, K., Pendse, S., Barker, G. F., Bray-Ward, P., Ward, D. C., Montgomery, K. T., Krauter, K. S., Reynolds, C., Sklar, J., Donnelly, M., Bohlander, S. K., Rowley, J D , Sallan, S E , Gilliland, D. G., and Golub, R T. Frequent loss of heterozygosity at the TEL sene locus in acute lymphoblastic leukemia of childhood. Blood, 86: 38-44, 1995.
59. Romana, S. P., Mauchauffe, M., Le Coniat, M., Chumakov, I., Le Paslier, D., Berger, R., and Bernard, O. A. The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion Blood, 85: 3662-3670, 1995
60. Golub, T. R., Barker, G. F., Bohlander, S. K., Hiebert, S. W., Ward, D C., Bray-Ward, P., Morgan, E., Raimondi, S C , Rowley, J. D , and Gilliland, D. G. Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia. Proc. Natl. Acad. Sci. USA, 92: 4917-4921, 1995.
61. Wlodarska, I , Mecucci, C., Marynen, P., Guo, C., Franckx, D , La Starza, R., Aventin, A , Bosly, A , Martelli, M. F., Cassiman, J. J., and Van den Berge, H. TEL gene is involved in myelodysplastic syndromes with either the typical t(5;12)(q33;p13) translocation or its variant t(10;12)(q24;p13). Blood, 85: 2848-2852, 1995.
62. Buijs, A., Sherr, S., van Baal, S , van Bezouw, S., van der Plas, D., Geurts van Kessel, A., Riegman, P , Lekanne Deprez, R , Zwarthoff, E., and Hagemeijer, A. Translocation (12;22) (p13;q11) in myeloproliferative disorders results in fusion of the ETS-like TEL gene on12p13 to the MN1 gene on 22q11. Oncogene, 10: 1511-1519, 1995.
63. Papadopoulos, P , Ridge, S. A , Boucher, C. A., Stocking, C., and Wiedemann, L. M. The novel activation of ABL by fusion to an ets-related gene, TEL. Cancer Res , 55: 34-38, 1995.
64. Sawyers, C. L., and Denny, C T. Chronic myelomonocytic leukemia Tel-a-kinase what Ets all about. Cell, 77: 171-173, 1994.
65. Kawamata, N , Morosetti, R., Miller, C. W , Park, D., Spirin, K. S , Nakamaki, T., Takeuchi, S., Hatta, Y., Simpson, J., Wilcyznski, S., and Koeffler, H. P. Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies. Cancer Res , 55: 2266-2269, 1995.
66. Gaypay, G., Morissette, J., Vignal, A., Dib, C., Fisames, C., Millaseau, P., Marc, S., Bernardi, G., Lathop, M , and Weissenbach, J. The 1993-94 genethon human genetic linkage map Nat. Genet., 7: 246-338, 1994.
67. Morosetti, R., Kawamata, N , Gombart, A. F , Miller, C. W , Hatta, Y., Hirama, T., Said, J. W., Tomonaga, M., and Koeffler, H. P. Alteranons of the p27/Kip1 gene in non-Hodgkin's lymphomas and adult T-cell leukemia/lymphoma. Blood, 86: 1924-1930, 1995.
68. Johnson, K R., Nousseef, W. M., Care, A., Wheelock, M. J., Hudson, S., Koeffler, H. P., Selsted, M., Miller, C., and Rovera, G. Characterisation of cDNA clones for human MPO: predicted amino acid sequence and evidence for multiple RNA species Nucleic Acids Res., 15: 1012-1023, 1987.
69. Shiohara, M , El-Deiry, W S., Wada, M., Nakamaki, T., Takeuchi, S , Yang, R., Chen, D. L., Vogelstein, B., and Koeffler, H. P. Absence of WAF1 mutations in a variety of human malignancies. Blood, 84: 3781-3784, 1994.
70. Raycroft, L., Schmidt, J. R., Yoas, K , Hao, M. M., and Lozano, G. Analysis of p53 mutants for transcriptional activity. Mol. Cell Biol., 11: 6067-6074, 1991
71. Pathak, S., Hopwood, V. L , Hortobagyi, G. N., Jackson, G. L., Hughes, J I., and Melillo, D Chromosome anomalies in human breast cancer evidence for specific involvement of Iq region in lymphocyte cultures Anticancer Res , 11: 1055-1060, 1991.
72. Mars, W M., and Saunders, G. F Chromosomal abnormalities in human breast cancer. Cancer Metastasis Rev , 9: 35-43, 1990
73. Loening, U. E. The fractionation of high molecular weight ribonucleic acids by polyacrylamide gel electrophoresis. Biochem. J., 107: 251-257, 1967.